Model cytotoxicity drug screening assays antitumor. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy25

Cell Line, Tumor Tumor Cells, Cultured Killer Cells, Natural Cell Line T-Lymphocytes, Cytotoxic Cells, Cultured T-Lymphocytes CD8-Positive T-Lymphocytes K562 Cells Lymphocytes Dendritic Cells Spleen HL-60 Cells Lymphocytes, Tumor-Infiltrating Killer Cells, Lymphokine-Activated Macrophages HT29 Cells Hep G2 Cells KB Cells HeLa Cells CD4-Positive T-Lymphocytes Fibroblasts Leukocytes, Mononuclear T-Lymphocytes, Regulatory HCT116 Cells

Organisms14

Mice, Nude Mice, Inbred BALB C Mice, Inbred C57BL Mice, SCID Oncolytic Viruses Adenoviridae Mice, Inbred C3H Mice, Inbred DBA Cricetinae Mice, Inbred Strains Streptomyces Cricetulus Mice, Transgenic Mice, Knockout

Diseases33

Leukemia P388 Neoplasms, Experimental Sarcoma 180 Melanoma, Experimental Leukemia L1210 Neoplasms Sarcoma, Experimental Colonic Neoplasms Melanoma Fibrosarcoma Lung Neoplasms Carcinoma, Lewis Lung Leukemia L5178 Mammary Neoplasms, Experimental Leukemia, Experimental Breast Neoplasms Carcinoma, Ehrlich Tumor Mast-Cell Sarcoma Ovarian Neoplasms Neovascularization, Pathologic Lymphoma Adenocarcinoma Liver Neoplasms Disease Models, Animal Neuroblastoma Glioma Leukemia Prostatic Neoplasms Kidney Neoplasms Neoplasm Metastasis Brain Neoplasms Necrosis Carcinoma, Hepatocellular

Chemicals and Drugs117

Antineoplastic Agents Antibiotics, Antineoplastic Cancer Vaccines Antineoplastic Agents, Phytogenic Antibodies, Monoclonal Cytotoxins Doxorubicin Antigens, Neoplasm Immunotoxins Enediynes Cisplatin Interleukin-2 Natural Cytotoxicity Triggering Receptor 1 Perforin Interferon-gamma Plant Extracts Prodrugs Tetrazolium Salts Drug Carriers Antineoplastic Agents, Alkylating Pore Forming Cytotoxic Proteins Enzyme Inhibitors Ellipticines Antibodies, Neoplasm Topoisomerase I Inhibitors Camptothecin Recombinant Proteins Thiazoles Angiogenesis Inhibitors Membrane Glycoproteins Natural Cytotoxicity Triggering Receptor 3 Natural Cytotoxicity Triggering Receptor 2 Indoles DNA Paclitaxel Amsacrine Tumor Necrosis Factor-alpha Interleukin-12 Mitomycin Ricin Reactive Oxygen Species Antimetabolites, Antineoplastic Antibodies, Bispecific Liposomes Topoisomerase II Inhibitors Caspase 3 Naphthoquinones Granzymes Intercalating Agents Glutathione Antigens, CD Chromium Radioisotopes Zinostatin Aminoacridines Caspases Adjuvants, Immunologic Triterpenes Receptors, IgG Fas Ligand Protein Naphthacenes Cytokines Aziridines L-Lactate Dehydrogenase NK Cell Lectin-Like Receptor Subfamily K Mitomycins Buthionine Sulfoximine Neoplasm Proteins Xanthones Recombinant Fusion Proteins Fluorouracil Benzoquinones Pyrazines DNA, Neoplasm Protein Kinase Inhibitors Quinazolines Anthraquinones Receptors, Immunologic Poly(ADP-ribose) Polymerases Receptors, Natural Killer Cell Bacterial Toxins Organoplatinum Compounds Complement System Proteins Nanocapsules Nitrogen Mustard Compounds Boronic Acids Alkylating Agents Polyethylene Glycols Daunorubicin Depsipeptides Acridines Antibodies, Monoclonal, Humanized RNA, Messenger Radiation-Sensitizing Agents Carmustine Diterpenes Deoxycytidine Immunoglobulin G Pyrroles Antigens, CD95 Cyclophosphamide Antigens, CD56 Etoposide DNA Topoisomerases, Type II Trypan Blue Proto-Oncogene Proteins c-bcl-2 RNA, Small Interfering Antioxidants Antigens, CD3 Aminoglycosides Exotoxins Dicumarol Plicamycin Maytansine Antigens, Surface Hydrogen Peroxide Polyethyleneimine Macrolides

Analytical, Diagnostic and Therapeutic Techniques and Equipment37

Drug Screening Assays, Antitumor Xenograft Model Antitumor Assays Cytotoxicity Tests, Immunologic Neoplasms, Experimental Neoplasm Transplantation Melanoma, Experimental Inhibitory Concentration 50 Immunotherapy Flow Cytometry Immunotherapy, Adoptive Sarcoma, Experimental Transplantation, Heterologous Lymphocyte Activation Genetic Therapy Oncolytic Virotherapy Drug Evaluation, Preclinical Drug Carriers Injections, Intralesional Tumor Burden Antineoplastic Combined Chemotherapy Protocols Transfection Mammary Neoplasms, Experimental Blotting, Western Leukemia, Experimental Tumor Stem Cell Assay Drug Delivery Systems Lethal Dose 50 Combined Modality Therapy Drug Administration Schedule Magnetic Resonance Spectroscopy Disease Models, Animal Nanocapsules Gene Transfer Techniques Toxicity Tests Injections, Intraperitoneal Reverse Transcriptase Polymerase Chain Reaction Drug Design

Phenomena and Processes36

Cytotoxicity, Immunologic Antibody-Dependent Cell Cytotoxicity Cell Survival Apoptosis Drug Synergism Dose-Response Relationship, Drug Inhibitory Concentration 50 Cell Proliferation Cell Death Cell Division Molecular Structure Lymphocyte Activation Drug Resistance, Neoplasm Structure-Activity Relationship Time Factors Cell Cycle Immunity, Cellular Genetic Vectors Transfection Signal Transduction DNA Damage Drug Resistance Lethal Dose 50 Cell Growth Processes Tumor Escape Particle Size Gene Expression Regulation, Neoplastic Kinetics Down-Regulation Dose-Response Relationship, Immunologic Biotransformation DNA Fragmentation Gene Expression Necrosis Phosphorylation Drug Interactions

Disciplines and Occupations1

Technology, Industry, Agriculture5

Nanoparticles Liposomes Nanocapsules Polyethylene Glycols Polyethyleneimine

Information Science1

Molecular Sequence Data

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Technology, Industry, Agriculture Information Science

Cytotoxicity, Immunologic Drug Screening Assays, Antitumor Antibody-Dependent Cell Cytotoxicity Antineoplastic Agents Xenograft Model Antitumor Assays Cell Line, Tumor Cytotoxicity Tests, Immunologic Cell Survival Tumor Cells, Cultured Antibiotics, Antineoplastic Killer Cells, Natural Leukemia P388 Neoplasms, Experimental Mice, Nude Apoptosis Drug Synergism Neoplasm Transplantation Sarcoma 180 Melanoma, Experimental Mice, Inbred BALB C Leukemia L1210 Dose-Response Relationship, Drug Neoplasms Cell Line Inhibitory Concentration 50 Immunotherapy Cancer Vaccines Antineoplastic Agents, Phytogenic Antibodies, Monoclonal Mice, Inbred C57BL Cell Proliferation Cytotoxins T-Lymphocytes, Cytotoxic Flow Cytometry Cell Death Doxorubicin Immunotherapy, Adoptive Mice, SCID Cells, Cultured Antigens, Neoplasm Cell Division Sarcoma, Experimental Colonic Neoplasms Immunotoxins Enediynes Melanoma Fibrosarcoma Transplantation, Heterologous Cisplatin Molecular Structure Interleukin-2 Natural Cytotoxicity Triggering Receptor 1 Perforin Lymphocyte Activation T-Lymphocytes Lung Neoplasms Genetic Therapy CD8-Positive T-Lymphocytes Interferon-gamma Drug Resistance, Neoplasm Oncolytic Virotherapy Structure-Activity Relationship Carcinoma, Lewis Lung K562 Cells Lymphocytes Plant Extracts Time Factors Prodrugs Tetrazolium Salts Oncolytic Viruses Adenoviridae Cell Cycle Drug Evaluation, Preclinical Drug Carriers Immunity, Cellular Injections, Intralesional Antineoplastic Agents, Alkylating Leukemia L5178 Genetic Vectors Pore Forming Cytotoxic Proteins Dendritic Cells Enzyme Inhibitors Spleen Ellipticines Tumor Burden Mice, Inbred C3H Antibodies, Neoplasm Antineoplastic Combined Chemotherapy Protocols Topoisomerase I Inhibitors Camptothecin HL-60 Cells Transfection Recombinant Proteins Thiazoles Signal Transduction Angiogenesis Inhibitors Mammary Neoplasms, Experimental Membrane Glycoproteins DNA Damage Blotting, Western

No FAQ available that match "model cytotoxicity drug screening assays antitumor"